More studies label controversial diabetes drug a heart disease risk

TORONTO - A mere two weeks before a critical hearing on the future of a controversial diabetes medication, new studies have been published that add to mounting evidence that the drug, Avandia, poses what critics describe as an unnecessary risk to people who take it....More